TC BioPharm (Holdings) plc - Warrants (TCBPW)

0.0095Last Price

-0.0005 (-5.00%)Change

TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmune®, To Treat Acute Myeloid Leukemiabenzinga.com

TC Biopharm (NASDAQTCBP) NASDAQ: TCBPWNASDAQTCBPW)

Via Benzinga · November 22, 2022